Ca2+-calmodulin-dependent protein kinase II represses cardiac transcription of the L-type calcium channel α1C-subunit gene (Cacna1c) by DREAM translocation

Journal of Physiology

Volumn 589, Issue 11, 2011, Pages 2669-2686

  Ronkainen, Jarkko J ^a   Hänninen, Sandra L ^a   Korhonen, Topi ^b   Koivumäki, Jussi T ^b   Skoumal, Reka ^a   Rautio, Sini ^a   Ronkainen, Veli Pekka ^a   Tavi, Pasi ^b  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTAB; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTAC; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL L TYPE ALPHA1C SUBUNIT; CALCIUM ION; CALSENILIN; GREEN FLUORESCENT PROTEIN; RNA; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED CALCIUM CHANNEL 1.2; BENZYLAMINE DERIVATIVE; BRAIN NATRIURETIC PEPTIDE; CSEN PROTEIN, MOUSE; CSEN PROTEIN, RAT; DNA; KV CHANNEL INTERACTING PROTEIN; L TYPE CALCIUM CHANNEL ALPHA(1C); L-TYPE CALCIUM CHANNEL ALPHA(1C); N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; REPRESSOR PROTEIN; SULFONAMIDE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CHANNEL L TYPE ALPHA1C SUBUNIT GENE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONSENSUS SEQUENCE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME ACTIVITY; ENZYME REGULATION; FEEDBACK SYSTEM; FLUORESCENCE ANALYSIS; GENE REPRESSION; HEART MUSCLE CELL; INHIBITION KINETICS; MATHEMATICAL MODEL; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ACTIVE TRANSPORT; ANIMAL; BINDING SITE; BIOLOGICAL MODEL; CELL CULTURE; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; ELECTROPHYSIOLOGY; EXCITATION CONTRACTION COUPLING; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE; PATCH CLAMP; PHYSIOLOGY; POINT MUTATION; RAT STRAIN; TUMOR CELL LINE; UPREGULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANIMALS, NEWBORN; BENZYLAMINES; BINDING SITES; CALCIUM CHANNELS, L-TYPE; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; DNA; DOWN-REGULATION; ELECTROPHYSIOLOGICAL PHENOMENA; EXCITATION CONTRACTION COUPLING; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION; GENE EXPRESSION REGULATION; KV CHANNEL-INTERACTING PROTEINS; MICE; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN; PATCH-CLAMP TECHNIQUES; POINT MUTATION; PROMOTER REGIONS, GENETIC; RATS; RATS, INBRED STRAINS; REPRESSOR PROTEINS; SEQUENCE DELETION; SULFONAMIDES; TRANSFECTION; UP-REGULATION;

EID: 79957832166     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2010.201400     Document Type: Article

References (67)

1. An WF, Bowlby MR, Betty M, Cao J, Ling HP, Mendoza G, Hinson JW, Mattsson KI, Strassle BW, Trimmer JS & Rhodes KJ (2000). Modulation of A-type potassium channels by a family of calcium sensors. Nature 403, 553-556.
2. Anderson ME (2004). Calmodulin kinase and L-type calcium channels: A recipe for arrhythmias? Trends Cardiovasc Med 14, 152-161.
3. 2+ release. Acta Physiol (Oxf) 191, 131-137.
4. Backs J, Backs T, Neef S, Kreusser MM, Lehmann LH, Patrick DM, Grueter CE, Qi X, Richardson JA, Hill JA, Katus HA, Bassel-Duby R, Maier LS & Olson EN (2009). The δ isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci U S A 106, 2342-2347.
5. Backs J, Song K, Bezprozvannaya S, Chang S & Olson EN (2006). CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J Clin Invest 116, 1853-1864.
6. Bers DM (2002). Cardiac excitation-contraction coupling. Nature 415, 198-205.
7. Bhalla US & Iyengar R (1999). Emergent properties of networks of biological signaling pathways. Science 283, 381-387.
8. Brickey DA, Bann JG, Fong YL, Perrino L, Brennan RG & Soderling TR (1994). Mutational analysis of the autoinhibitory domain of calmodulin kinase II. J Biol Chem 269, 29047-29054.
9. Brundel BJJM, Van Gelder IC, Henning RH, Tuinenburg AE, Deelman LE, Tieleman RG, Grandjean JG, Van Gilst WH & Crijns HJGM (1999). Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. Cardiovasc Res 42, 443-454.
10. 2+-regulated transcriptional repressor. Nature 398, 80-84.
11. 2+ channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanical assist devices. Circ Res 91, 517-524.
12. Cheng HY, Pitcher GM, Laviolette SR, Whishaw IQ, Tong KI, Kockeritz LK, Wada T, Joza NA, Crackower M, Goncalves J, Sarosi I, Woodgett JR, Oliveira-dos-Santos AJ, Ikura M, van der Kooy D, Salter MW & Penninger JM (2002). DREAM is a critical transcriptional repressor for pain modulation. Cell 108, 31-43.
13. 2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 110, 2651-2657.
14. Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A & Izzo NJ (1998). HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 95, 2979-2984.
15. Drummond GB (2009). Reporting ethical matters in The Journal of Physiology: standards and advice. J Physiol 587, 713-719.
16. Dzhura I, Wu Y, Colbran RJ, Balser JR & Anderson ME (2000). Calmodulin kinase determines calcium-dependent facilitation of L-type calcium channels. Nat Cell Biol 2, 173-177.
17. Engelhardt S, Hein L, Dyachenkow V, Kranias EG, Isenberg G & Lohse MJ (2004). Altered calcium handling is critically involved in the cardiotoxic effects of chronic β-adrenergic stimulation. Circulation 109, 1154-1160.
18. 1C subunit expression in vascular smooth muscle cells. Biochim Biophys Acta 1577, 401-411.
19. Ferrier GR, Zhu JQ, Redondo IM & Howlett SE (1998). Role of cAMP-dependent protein kinase A in activation of a voltage-sensitive release mechanism for cardiac contraction in guinea-pig myocytes. J Physiol 513, 185-201.
20. Frey N, McKinsey TA & Olson EN (2000). Decoding calcium signals involved in cardiac growth and function. Nat Med 6, 1221-1227.
21. Gaborit N, Steenman M, Lamirault G, Le Meur N, Le Bouter S, Lande G, Leger J, Charpentier F, Christ T, Dobrev D, Escande D, Nattel S & Demolombe S (2005). Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation 112, 471-481.
22. 2+ homeostasis and viability in cerebellar neurons. J Neurosci 25, 10822-10830.
23. Ikura M, Osawa M & Ames JB (2002). The role of calcium-binding proteins in the control of transcription: structure to function. Bioessays 24, 625-636.
24. 2+ release, but normal ryanodine receptors, in canine and human heart failure. Circ Res 91, 1015-1022.
25. Klein G, Schroder F, Vogler D, Schaefer A, Haverich A, Schieffer B, Korte T & Drexler H (2003). Increased open probability of single cardiac L-type calcium channels in patients with chronic atrial fibrillation: Role of phosphatase 2A. Cardiovasc Res 59, 37-45.
26. Kohlhaas M, Zhang T, Seidler T, Zibrova D, Dybkova N, Steen A, Wagner S, Chen L, Brown JH, Bers DM & Maier LS (2006). Increased sarcoplasmic reticulum calcium leak but unaltered contractility by acute CaMKII overexpression in isolated rabbit cardiac myocytes. Circ Res 98, 235-244.
27. Koivumaki JT, Korhonen T, Takalo J, Weckstrom M & Tavi P (2009). Regulation of excitation-contraction coupling in mouse cardiac myocytes: integrative analysis with mathematical modelling. BMC Physiol 9, 16.
28. 2+-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: An insight into the mechanism of atrial electrical remodeling. J Am Coll Cardiol 33, 1231-1237.
29. Ledo F, Carrion AM, Link WA, Mellstrom B & Naranjo JR (2000). DREAM-αCREM interaction via leucine-charged domains derepresses downstream regulatory element-dependent transcription. Mol Cell Biol 20, 9120-9126.
30. v1.2 calcium channel: Identification of the phosphorylation sites. J Biol Chem 281, 25560-25567.
31. Little GH, Bai Y, Williams T & Poizat C (2007). Nuclear calcium/calmodulin-dependent protein kinase IIδ preferentially transmits signals to histone deacetylase 4 in cardiac cells. J Biol Chem 282, 7219-7231.
32. Liu L, Fan QI, El-Zaru MR, Vanderpool K, Hines RN & Marsh JD (2000). Regulation of DHP receptor expression by elements in the 5'-flanking sequence. Am J Physiol Heart Circ Physiol 278, H1153-H1162.
33. Lory P & Nargeot J (1992). Cyclic AMP-dependent modulation of cardiac Ca channels expressed in Xenopus laevis oocytes. Biochem Biophys Res Commun 182, 1059-1065.
34. McKinsey TA (2007). Derepression of pathological cardiac genes by members of the CaM kinase superfamily. Cardiovasc Res 73, 667-677.
35. McKinsey TA, Zhang CL, Lu JR & Olson EN (2000). Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408, 106-111.
36. Maier LS (2009). Role of CaMKII for signaling and regulation in the heart. Front Biosci 14, 486-496.
37. 2+ release. Circ Res 92, 904-911.
38. 2+-dependent regulation of calcitonin gene expression by the transcriptional repressor DREAM. Endocrinology 147, 4608-4617.
39. 2+-dependent transcriptional repression and derepression: DREAM, a direct effector. Semin Cell Dev Biol 12, 59-63.
40. Molkentin JD, Black BL, Martin JF & Olson EN (1995). Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83, 1125-1136.
41. Nordeen SK ( 1988). Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6, 454-458.
42. Olson EN & Schneider MD (2003). Sizing up the heart: development redux in disease. Genes Dev 17, 1937-1956.
43. 2+-dependent inactivation of L-type calcium channels. Neuron 22, 549-558.
44. Piacentino V, Weber CR, Chen XW, Weisser-Thomas J, Margulies KB, Bers DM & Houser SR (2003). Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ Res 92, 651-658.
45. 2+/calmodulin-dependent protein kinase II regulates atrial natriuretic factor gene expression ventricular myocytes. J Biol Chem 272, 31203-31208.
46. Reuter H, Han TY, Motter C, Philipson KD & Goldhaber JI (2004). Mice overexpressing the cardiac sodium-calcium exchanger: defects in excitation-contraction coupling. J Physiol 554, 779-789.
47. Rivas M, Mellstrom B, Naranjo JR & Santisteban P (2004). Transcriptional repressor DREAM interacts with thyroid transcription factor-1 and regulates thyroglobulin gene expression. J Biol Chem 279, 33114-33122.
48. Ronkainen JJ, Vuolteenaho O & Tavi P (2007). Calcium-calmodulin kinase II is the common factor in calcium-dependent cardiac expression and secretion of A- and B-type natriuretic peptides. Endocrinology 148, 2815-2820.
49. Saito T, Fukuzawa J, Osaki J, Sakuragi H, Yao N, Haneda T, Fujino T, Wakamiya N, Kikuchi K & Hasebe N (2003). Roles of calcineurin and calcium/calmodulin-dependent protein kinase II in pressure overload-induced cardiac hypertrophy. J Mol Cell Cardiol 35, 1153-1160.
50. Sanz C, Mellstrom B, Link WA, Naranjo JR & Fernandez-Luna JL (2001). Interleukin 3-dependent activation of DREAM is involved in transcriptional silencing of the apoptotic hrk gene in hematopoietic progenitor cells. EMBO J 20, 2286-2292.
51. Savignac M, Pintado B, Gutierrez-Adan A, Palczewska M, Mellstrom B & Naranjo JR (2005). Transcriptional repressor DREAM regulates T-lymphocyte proliferation and cytokine gene expression. EMBO J 24, 3555-3564.
52. Schreiber E, Matthias P, Muller MM & Schaffner W (1989). Rapid detection of octamer binding-proteins with mini-extracts, prepared from a small number of cells. Nucleic Acids Res 17, 6419-6419.
53. v1.2 channels by p50 and p65 subunits of nuclear factor-κB. Gastroenterology 129, 1518-1532.
54. 2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest 90, 927-935.
55. Tang HB, Macpherson P, Argetsinger LS, Cieslak D, Suhr ST, Carter-Su C & Goldman D (2004). CaM kinase II-dependent phosphorylation of myogenin contributes to activity-dependent suppression of nAChR gene expression in developing rat myotubes. Cell Signal 16, 551-563.
56. 2+ release in mouse skeletal muscle. J Physiol 551, 5-12.
57. 2+ release and catecholamine-induced arrhythmias in mitochondrial cardiomyopathy. Hum Mol Gen 14, 1069-1076.
58. Tsai CT, Wang DL, Chen WP, Hwang JJ, Hsieh CS, Hsu KL, Tseng CD, Lai LP, Tseng YZ, Chiang FT & Lin JL (2007). Angiotensin II increases expression of α1C subunit of L-type calcium channel through a reactive oxygen species and cAMP response element-binding protein-dependent pathway in HL-1 myocytes. Circ Res 100, 1476-1485.
59. 2+ channels in neonatal rat heart. J Mol Cell Cardiol 42, 1045-1053.
60. 2+ signaling in cardiac myocyte excitation-transcription coupling. J Clin Invest 116, 675-682.
61. 2+ current in rabbit ventricular myocytes by a common mechanism. J Physiol 535, 679-687.
62. Xu L, Lai D, Cheng J, Lim HJ, Keskanokwong T, Backs J, Olson EN & Wang Y (2010). Alterations of L-type calcium current and cardiac function in CaMKIIδ knockout mice. Circ Res 107, 398-407.
63. Yang Z, Shen W, Rottman JN, Wikswo JP & Murray KT (2005). Rapid stimulation causes electrical remodeling in cultured atrial myocytes. J Mol Cell Cardiol 38, 299-308.
64. Zaidi NF, Thomson EE, Choi EK, Buxbaum JD & Wasco W (2004). Intracellular calcium modulates the nuclear translocation of calsenilin. J Neurochem 89, 593-601.
65. 2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovasc Res 63, 476-486.
66. 2+/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity. J Biol Chem 277, 1261-1267.
67. C isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res 92, 912-919.